{"protocolSection":{"identificationModule":{"nctId":"NCT04089917","orgStudyIdInfo":{"id":"101347"},"organization":{"fullName":"MIVI Neuroscience, Inc.","class":"INDUSTRY"},"briefTitle":"A Study of the Use of the Q Aspiration Catheter to Remove Clot in Stroke Patients","officialTitle":"An Observational Study of the Q Aspiration Catheter Used During Neurointervention for Acute Large Vessel Ischemic Stroke in Spain.","acronym":"TAPAS"},"statusModule":{"statusVerifiedDate":"2022-10","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2019-09-16","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2021-03-30","type":"ACTUAL"},"completionDateStruct":{"date":"2021-11-23","type":"ACTUAL"},"studyFirstSubmitDate":"2019-08-21","studyFirstSubmitQcDate":"2019-09-12","studyFirstPostDateStruct":{"date":"2019-09-13","type":"ACTUAL"},"resultsFirstSubmitDate":"2022-10-28","resultsFirstSubmitQcDate":"2022-10-28","resultsFirstPostDateStruct":{"date":"2023-09-07","type":"ACTUAL"},"lastUpdateSubmitDate":"2022-10-28","lastUpdatePostDateStruct":{"date":"2023-09-07","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"MIVI Neuroscience, Inc.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The purpose of this study is to collect real-world safety and performance data on the MIVI Neuroscience, Inc. Q Aspiration Catheter for use in the removal of fresh, soft emboli and thrombi in the neurovascular system during acute ischemic stroke.","detailedDescription":"The purpose of this study is to demonstrate the safety and performance of the MIVI Neuroscience, Inc. CE Marked Q Aspiration Catheter for use in the removal of fresh, soft emboli and thrombi in the neurovascular system during acute ischemic stroke. The study is an observational study collecting Q Aspiration Catheter use that will enroll a maximum of 50 subjects at a maximum of 5 sites in Spain. Subjects data will be collected through hospitalization with a 3 months post-procedure study visit. This study is designed for observational data to be collected and reported."},"conditionsModule":{"conditions":["Stroke, Ischemic"],"keywords":["Mechanical thrombectomy","Acute ischemic stroke","neurovascular intervention"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"RETROSPECTIVE"},"enrollmentInfo":{"count":45,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Q Aspiration Catheter","description":"mechanical thrombectomy for acute ischemic stroke","interventionNames":["Device: Q Aspiration Catheter"]}],"interventions":[{"type":"DEVICE","name":"Q Aspiration Catheter","description":"The Q Aspiration Catheter is indicated for use in the removal of fresh, soft emboli and thrombi in the neurovascular system.","armGroupLabels":["Q Aspiration Catheter"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Successful Revascularization Rate","description":"Defined as final modified Thrombolysis In Cerebral Infarction scale (mTICI 2b-3) flow in the target vessel","timeFrame":"intra-procedural"},{"measure":"Symptomatic Intracranial Haemorrhage Rate","description":"Defined as the symptomatic intracranial haemorrhage as detected by CT/MRI with an NIHSS change of \\>/= 4 points","timeFrame":"24 hours post procedure"}],"secondaryOutcomes":[{"measure":"Successful Revascularization Rate Using the Q Aspiration Catheter as the Only Thrombectomy Device","description":"Defined as mTICI 2b-3 flow in the target vessel post-treatment with the Q Catheter (first line therapy)","timeFrame":"intra-procedural"},{"measure":"Rate of Embolization to a New Neurovascular Territory (ENT)","description":"As measured by independent Angiographic Core Lab","timeFrame":"intra-procedural"},{"measure":"Good Functional Outcome Measured by Modified Rankin Scale Score of 0-2","description":"The Modified Rankin Scale (mRS) measures neurological disability or dependence for stroke patients on a scale of 0 (no symptoms) to 6 (deceased).","timeFrame":"90 days"},{"measure":"Mortality Rate","description":"Rate of all cause mortality","timeFrame":"90 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age 18 to 85 years;\n* Diagnosis of acute ischemic stroke with mechanical thrombectomy procedure \\< 8 hours from onset of symptoms/ last known well;\n* Large Vessel Occlusion on CT or MRI in the anterior cerebral vasculature up to A1, M1, or M2 or the posterior cerebral vasculature;\n* ASPECTS 6 - 10 or volume of diffusion restriction \\< 50 mL;\n* Use of the Q Aspiration Catheter as the first line treatment according to the IFU;\n* Signed informed consent by patient or legally authorized representative.\n\nExclusion Criteria:\n\n* Occlusions in multiple vascular territories, extracranial occlusion or tandem occlusion;\n* Evidence of dissection in the carotid or target artery for treatment;\n* Evidence of recent/fresh haemorrhage on presentation;\n* Unwilling to agree to a 3-month follow up visit.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Population is patients diagnosed with large vessel occlusion acute ischemic stroke within 8 hours of stroke onset treated with mechanical aspiration thrombectomy with the Q Aspiration Catheter as first line therapy.","samplingMethod":"PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Mariano Espinosa de Rueda Ruiz, MD","affiliation":"Neurorradiologia Intervencionista, HCUVA, Murcia","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Hospital Universitario 12 De Octubre","city":"Madrid","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"Hospital Virgen de la Arrixaca","city":"Murcia","country":"Spain","geoPoint":{"lat":37.98704,"lon":-1.13004}},{"facility":"Centro Hospitalario Universitario Donostia","city":"San SebastiÃ¡n","country":"Spain","geoPoint":{"lat":43.31283,"lon":-1.97499}},{"facility":"Hospital Universitario de Santiago de Compostela","city":"Santiago De Compostela","country":"Spain","geoPoint":{"lat":42.88052,"lon":-8.54569}}]},"referencesModule":{"references":[{"pmid":"35641183","type":"RESULT","citation":"Espinosa de Rueda M, Ballenilla Marco F, Garmendia Lopetegui E, Pumar JM, Zamarro J, Garcia-Villalba B, Diaz-Perez J, Mosqueira A, Luttich A, Larrea JA, Parrilla G. Thrombectomy aspiration post-market study in acute stroke with the Q aspiration catheter: the TAPAS study. J Neurointerv Surg. 2023 Jul;15(7):674-678. doi: 10.1136/neurintsurg-2022-018649. Epub 2022 May 31."}],"seeAlsoLinks":[{"label":"Thrombectomy aspiration post-market study in acute stroke with the Q aspiration catheter: the TAPAS study","url":"https://jnis.bmj.com/content/early/2022/05/31/neurintsurg-2022-018649"}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"Q Aspiration Catheter","description":"mechanical thrombectomy for acute ischemic stroke\n\nQ Aspiration Catheter: The Q Aspiration Catheter is indicated for use in the removal of fresh, soft emboli and thrombi in the neurovascular system."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"45"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"45"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Q Aspiration Catheter","description":"mechanical thrombectomy for acute ischemic stroke\n\nQ Aspiration Catheter: The Q Aspiration Catheter is indicated for use in the removal of fresh, soft emboli and thrombi in the neurovascular system."}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"45"}]}],"measures":[{"title":"Age, Categorical","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"45"}]}],"categories":[{"title":"<=18 years","measurements":[{"groupId":"BG000","value":"0"}]},{"title":"Between 18 and 65 years","measurements":[{"groupId":"BG000","value":"7"}]},{"title":">=65 years","measurements":[{"groupId":"BG000","value":"38"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"45"}]}],"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"21"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"24"}]}]}]},{"title":"Race and Ethnicity Not Collected","populationDescription":"Race and Ethnicity were not collected from any participant.","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"0"}]}]}]},{"title":"Region of Enrollment","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"Spain","denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"45"}]}],"categories":[{"measurements":[{"groupId":"BG000","value":"45"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Successful Revascularization Rate","description":"Defined as final modified Thrombolysis In Cerebral Infarction scale (mTICI 2b-3) flow in the target vessel","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"intra-procedural","groups":[{"id":"OG000","title":"Q Aspiration Catheter","description":"mechanical thrombectomy for acute ischemic stroke\n\nQ Aspiration Catheter: The Q Aspiration Catheter is indicated for use in the removal of fresh, soft emboli and thrombi in the neurovascular system."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"45"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42"}]}]}]},{"type":"PRIMARY","title":"Symptomatic Intracranial Haemorrhage Rate","description":"Defined as the symptomatic intracranial haemorrhage as detected by CT/MRI with an NIHSS change of \\>/= 4 points","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"24 hours post procedure","groups":[{"id":"OG000","title":"Q Aspiration Catheter","description":"mechanical thrombectomy for acute ischemic stroke\n\nQ Aspiration Catheter: The Q Aspiration Catheter is indicated for use in the removal of fresh, soft emboli and thrombi in the neurovascular system."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"45"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}]}]},{"type":"SECONDARY","title":"Successful Revascularization Rate Using the Q Aspiration Catheter as the Only Thrombectomy Device","description":"Defined as mTICI 2b-3 flow in the target vessel post-treatment with the Q Catheter (first line therapy)","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"intra-procedural","groups":[{"id":"OG000","title":"Q Aspiration Catheter","description":"mechanical thrombectomy for acute ischemic stroke\n\nQ Aspiration Catheter: The Q Aspiration Catheter is indicated for use in the removal of fresh, soft emboli and thrombi in the neurovascular system."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"38"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25"}]}]}]},{"type":"SECONDARY","title":"Rate of Embolization to a New Neurovascular Territory (ENT)","description":"As measured by independent Angiographic Core Lab","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"intra-procedural","groups":[{"id":"OG000","title":"Q Aspiration Catheter","description":"mechanical thrombectomy for acute ischemic stroke\n\nQ Aspiration Catheter: The Q Aspiration Catheter is indicated for use in the removal of fresh, soft emboli and thrombi in the neurovascular system."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"45"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}]},{"type":"SECONDARY","title":"Good Functional Outcome Measured by Modified Rankin Scale Score of 0-2","description":"The Modified Rankin Scale (mRS) measures neurological disability or dependence for stroke patients on a scale of 0 (no symptoms) to 6 (deceased).","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"90 days","groups":[{"id":"OG000","title":"Q Aspiration Catheter","description":"mechanical thrombectomy for acute ischemic stroke\n\nQ Aspiration Catheter: The Q Aspiration Catheter is indicated for use in the removal of fresh, soft emboli and thrombi in the neurovascular system."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"45"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25"}]}]}]},{"type":"SECONDARY","title":"Mortality Rate","description":"Rate of all cause mortality","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"90 days","groups":[{"id":"OG000","title":"Q Aspiration Catheter","description":"mechanical thrombectomy for acute ischemic stroke\n\nQ Aspiration Catheter: The Q Aspiration Catheter is indicated for use in the removal of fresh, soft emboli and thrombi in the neurovascular system."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"45"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"From procedure through subject 3 month follow up visit, serious adverse events were collected","eventGroups":[{"id":"EG000","title":"Q Aspiration Catheter","description":"mechanical thrombectomy for acute ischemic stroke\n\nQ Aspiration Catheter: The Q Aspiration Catheter is indicated for use in the removal of fresh, soft emboli and thrombi in the neurovascular system.","deathsNumAffected":7,"deathsNumAtRisk":45,"seriousNumAffected":11,"seriousNumAtRisk":45,"otherNumAffected":6,"otherNumAtRisk":45}],"seriousEvents":[{"term":"Hemorrhagic transformation","organSystem":"General disorders","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":45}]},{"term":"Death of unknown cause","organSystem":"General disorders","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":45}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":45}]},{"term":"mechanical ventilation complications","organSystem":"Respiratory, thoracic and mediastinal disorders","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":45}]}],"otherEvents":[{"term":"procedural complication","organSystem":"Injury, poisoning and procedural complications","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","notes":"vasospasm, vessel dissection, and/or access site complication","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":45}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"pointOfContact":{"title":"Mariano Espinosa de Rueda","organization":"Department of Interventional Neuroradiology, Hospital ClÃ­nico Universitario Virgen de la Arrixaca, Murcia, Spain","email":"mm.espinosa@gmail.com","phone":"+34 968 36 96 42"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot_SAP","hasProtocol":true,"hasSap":true,"hasIcf":false,"label":"Study Protocol and Statistical Analysis Plan","date":"2019-08-01","uploadDate":"2022-10-28T13:10","filename":"Prot_SAP_000.pdf","size":503345}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Stroke, Ischemic","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":true}